Growth Metrics

Quantum Biopharma (QNTM) Non Operating Investment Income (2020 - 2026)

Quantum Biopharma recorded quarterly Non Operating Investment Income of $235807.0 in Q1 2026, up 261.17% quarter-over-quarter from -$146308.0 in Q3 2025.

Quantum Biopharma's Non Operating Investment Income history runs 7 years deep, the most recent figure standing at $235807.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 235,807.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 230,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 235,807.00
Mar 31, 2026 235,807.00
Sep 30, 2025 -146,308.00
Sep 30, 2025 -146,308.00
Jun 30, 2025 -6,572.00
Jun 30, 2025 -6,572.00
Mar 31, 2024 -23,297.00
Mar 31, 2024 -23,297.00
Sep 30, 2023 8,032.00
Sep 30, 2023 8,032.00
Jun 30, 2023 -328,193.00
Jun 30, 2023 -328,193.00
Mar 31, 2023 206,950.00
Mar 31, 2023 206,950.00
Sep 30, 2022 -37,139.00
Sep 30, 2022 -37,139.00
Jun 30, 2022 -97,264.00
Jun 30, 2022 -97,264.00
Mar 31, 2022 -242,519.00
Mar 31, 2022 -242,519.00
Sep 30, 2021 -242,502.00
Sep 30, 2021 -242,502.00
Jun 30, 2021 -294,947.00
Jun 30, 2021 -294,947.00
Mar 31, 2021 556,556.00
Mar 31, 2021 556,556.00
Sep 30, 2020 -671,065.62
Sep 30, 2020 -671,065.62
Mar 31, 2020 -629,013.65
Mar 31, 2020 -629,013.65